Popular Diabetes Drugs Used for Weight Loss Under Investigation for Suicide Risk

Contact Your Elected Officials
The Epoch Times Header

The European Union’s drug regulator is probing a possible link between diabetes drugs, popular for weight loss, and suicidal thoughts.

The European Medicines Agency (EMA) is assessing 150 reports of possible cases of self-injury among people taking a class of medications called GLP-1 agonists, which play a role in regulating metabolism and hunger.

The EMA said the Icelandic Medicines Agency initiated the review due to reports of suicidal thoughts and self-injury in individuals using liraglutide and semaglutide drugs for weight loss.

Semaglutide belongs to the glucagon-like peptide-1 (GLP-1) receptor agonists sold under the brand name Ozempic. In 2014, the U.S. Food and Drug Administration (FDA) approved semaglutide for weight loss among obese or overweight people with at least one weight-related condition, such as high blood pressure, Type 2 diabetes, or high cholesterol. For them, semaglutide is sold under the name Wegovy, which is a higher-dose version of Ozempic.

“It’s important to note that the EMA review is only for GLP-1s indicated for obesity,” Ambre James-Brown, global vice president of Media & Digital Global Communication at Novo Nordisk, told The Epoch Times. “The EMA review does not include diabetes medications, meaning this is not an investigation of Ozempic.”

While the investigation is ongoing, the EMA has advised health care professionals to monitor patients taking this class of drugs for signs of suicidal thoughts or behavior.

Suicidal Behavior Linked to These Meds Has Been Noted Before

GLP-1 agonists were introduced to the market in 2005. The FDA approved (pdf) Novo Nordisk’s GLP-1 agonist liraglutide (brand name Victoza) in 2010 to treat diabetes, and the company’s drug Ozempic was FDA-approved for diabetes treatment in 2017.

A 2020 clinical review (pdf) by the FDA did caution about a potential association between liraglutide and suicidal thoughts in adolescents.

According to the review, suicidal behavior was observed in both a placebo group and the group receiving liraglutide. The agency found no significant imbalance of psychiatric events overall but noted that obese adolescents may be at a higher risk for suicidality and depression.

By George Citroner

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Government Shutdown, Health Care, Tax Breaks=Perfect Storm

The shutdown over cuts to health subsidies for the poor stems from Trump’s OBBB plan, which critics say funneled trillions to the wealthy.

3I/Atlas Comet or UFO Arrives Tomorrow!

The 3I/Atlas object is hurtling toward our solar system on a strange path and composition, set to pass behind the sun, obscuring visual and radio tracking.

‘I’d Be Finished’: Vaccine Researcher Trashes Own Study to Save Career

Most doctors comply with the system, following orders to keep their jobs, income, and prestige, even if it means setting aside independent judgment.

Kamala, Please Run Again

Kamala Harris hinted she wants to run for President in 2028, despite poor poll numbers and her loss in 2024. If she runs, the big winners will be the GOP.

Rosie O’Donnell vs. Her Therapist

Rosie O’Donnell's therapist attempted to artfully introduce to her client to the possibility that Rosie's outrage might be performative. It didn’t take.

Federal Judge Extends Order Blocking Firings During Shutdown

A federal judge on Oct. 28 indefinitely blocked the Trump administration from firing federal employees during the ongoing federal government shutdown.

Los Angeles Dethrones Chicago as ‘Rattiest’ US City

Los Angeles has dethroned Chicago as the “rattiest” U.S. city after more than a decade, becoming the new top haven for rodents.

Prediction of Climate Catastrophe Loses Some of Its Strongest Advocates

Bill Gates says the “doomsday view” of climate catastrophe is wrong, signaling a major shift in the global warming debate.

DOJ to Review Biden’s Use of Autopen for Pardons

The DOJ will review the Biden administration’s use of an autopen for thousands of pardons, U.S. Attorney General Pam Bondi confirmed Tuesday.

Trump, Japanese PM Sign Critical Minerals, Rare Earths Deal

The U.S. president visited Tokyo on the second leg...

Trump Hikes Canada’s Tariffs by 10 Percent for Not Pulling Anti-Tariff Ad Immediately

Trump announced he will increase tariffs on Canada by 10% after ad by provincial government of Ontario misrepresented President Reagan’s speech on tariffs.

Trump Rolls Back Emissions Rules on Copper Smelters

President Trump issued a proclamation aimed at reversing a Biden-era environmental rule that enforced stricter air emission standards on copper smelters.

Donor Gives $130 Million to Cover Shortfall in Troop Pay During Shutdown

Trump announced on Oct. 23 that an anonymous donor sent $130M to cover military pay during the ongoing government shutdown.
spot_img

Related Articles

Popular Categories

MAGA Business Central